PubRank

Masami Tabata

Author PubWeight™ 31.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinicopathological features and prognosis of mucin-producing bile duct tumor and mucinous cystic tumor of the liver: a multi-institutional study by the Japan Biliary Association. J Hepatobiliary Pancreat Sci 2013 1.42
2 Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy. J Hepatobiliary Pancreat Sci 2012 1.20
3 Laparoscopic splenectomy for a huge splenic cyst without preoperative drainage: report of a case. Surg Laparosc Endosc Percutan Tech 2003 1.03
4 Pancreaticoduodenectomy with resection of the splenic artery and splenectomy for pancreatic double cancers after total gastrectomy. Preservation of the pancreatic function via the blood supply from the posterior epiploic artery: report of a case. Surg Today 2011 0.98
5 Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Sci 2009 0.93
6 Laparoscopic spleen-preserving pancreatic tail resection for an intrapancreatic accessory spleen mimicking a nonfunctioning endocrine tumor: report of a case. Surg Today 2004 0.93
7 Surgical treatment of type IV choledochal cysts. J Hepatobiliary Pancreat Surg 2009 0.89
8 Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepatobiliary Pancreat Sci 2015 0.88
9 Monitoring peripheral blood CD4+ adenosine triphosphate activity after living donor liver transplantation: impact of combination assays of immune function and CYP3A5 genotype. J Hepatobiliary Pancreat Sci 2011 0.87
10 Intrahepatic hepatic vein stenosis after living-related liver transplantation treated by insertion of an expandable metallic stent. Am J Transplant 2004 0.87
11 Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies. J Gastrointest Surg 2002 0.87
12 The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2006 0.86
13 Donor outcome and liver regeneration after right-lobe graft donation. Transpl Int 2005 0.85
14 Activated protein C prevents hepatic ischaemia-reperfusion injury in rats. Liver Int 2008 0.85
15 A standardized technique for safe pancreaticojejunostomy: Pair-Watch suturing technique. World J Gastrointest Surg 2010 0.84
16 Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expression. Pancreas 2014 0.84
17 Outflow block secondary to stenosis of the inferior vena cava following living-donor liver transplantation? Clin Transplant 2005 0.84
18 Benefit of technetium-99m galactosyl human serum albumin scintigraphy instead of indocyanine green test in patients scheduled for hepatectomy. Hepatol Res 2014 0.83
19 Tissue factor expression demonstrates severe sinusoidal endothelial cell damage during rejection after living-donor liver transplantation. J Hepatobiliary Pancreat Surg 2009 0.83
20 Using a radial artery as an interpositional vascular graft in a living-donor liver transplantation for hepatocellular carcinoma. Transpl Int 2005 0.82
21 Hepatic mucosa-associated lymphoid tissue (MALT) lymphoma associated with hepatitis C. J Hepatol 2002 0.81
22 Total vascular hepatic exclusion for tumor resection: a new approach to the intrathoracic inferior vena cava through the abdominal cavity by cutting the diaphragm vertically without cutting the pericardium. J Hepatobiliary Pancreat Sci 2010 0.81
23 Prospective study on the outcome of patients with hepatocellular carcinoma registered for living donor liver transplantation: how long can they wait? Transplantation 2010 0.81
24 Anterior approach to the superior mesenteric artery by using nerve plexus hanging maneuver for borderline resectable pancreatic head carcinoma. J Gastrointest Surg 2014 0.80
25 Proposal for a morphological classification of intraductal papillary neoplasm of the bile duct (IPN-B). J Hepatobiliary Pancreat Sci 2013 0.80
26 Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci 2014 0.80
27 Laparoscopy assisted middle-segment-preserving pancreatectomy for multiple pancreatic neuroendocrine tumors: report of a case. Asian J Endosc Surg 2014 0.80
28 Successful laparoscopic splenectomy after living-donor liver transplantation for thrombocytopenia caused by antiviral therapy. World J Gastroenterol 2008 0.80
29 Early graft hemodynamics in living related liver transplantation evaluated by Doppler ultrasonography. Int J Mol Med 2004 0.79
30 Approach to fine-needle aspiration cytology-negative cases of breast cancer. Asian J Surg 2005 0.79
31 The cytoprotective effects of addition of activated protein C into preservation solution on small-for-size grafts in rats. Liver Transpl 2010 0.79
32 Dual cytoprotective effects of splenectomy for small-for-size liver transplantation in rats. Liver Transpl 2012 0.79
33 Maximizing venous outflow after right hepatic living donor liver transplantation with a venous graft patch. Dig Surg 2008 0.78
34 Immunological aspects in late phase of living donor liver transplant patients: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity. Clin Dev Immunol 2013 0.78
35 Bacterial analysis of infected pancreatic necrosis and its prevention (Symposium 8: Pancreatobiliary infection (IHPBA)). J Hepatobiliary Pancreat Surg 2003 0.77
36 Impact of histological response after neoadjuvant chemoradiotherapy on recurrence-free survival in UICC-T3 pancreatic adenocarcinoma but not in UICC-T4. Pancreas 2012 0.77
37 Liver retransplantation with external biliary diversion for progressive familial intrahepatic cholestasis type 1: a case report. Pediatr Transplant 2008 0.76
38 Combination assays for evaluation of immune function and CYP3A5 genotype to identify the risk of infectious complications and mortality in living donor liver transplant patients. Ann Transplant 2013 0.75
39 [Studies on the distribution of doripenem in pancreatic tissues, especially on the importance of the ratio in pancreatic tissue concentration of doripenem/serum concentration of doripenem]. Jpn J Antibiot 2014 0.75
40 Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of splenectomy: the significance of ADAMTS13 and graft function [corrected]. Int J Hematol 2014 0.75
41 Lethal hepatic infarction following plasma exchange in living donor liver transplant patients. Transpl Int 2011 0.75
42 [A case report of advanced gastric remnant cancer treated with extended resection accompanied with reconstructions of the portal vein and the hepatic artery with resultant disease free survival for one year and eight months]. Nihon Shokakibyo Gakkai Zasshi 2005 0.75
43 Hepaticojejunostomy by interventional radiology with an expandable metallic stent after extended right hepatectomy for hilar cholangiocarcinoma: case report. Surg Laparosc Endosc Percutan Tech 2008 0.75
44 An approach to the intra-thoracic inferior vena cava through the abdominal cavity preparing for total hepatic vascular exclusion by sagittal diaphragmotomy. Hepatogastroenterology 2013 0.75
45 Effect of a prostaglandin I(2) analog on the expression of thrombomodulin in liver and spleen endothelial cells after an extensive hepatectomy. Surg Today 2011 0.75
46 [A Case of Primary Peritoneal Cancer Successfully Treated with Debulking Surgery and Postoperative Chemotherapy]. Gan To Kagaku Ryoho 2016 0.75